Paper

1. Yukako Soejima, Hideki Yoshioka, Sayuri Guro, Hiromi Sato, Hiroto Hatakeyama,  Yasunori SATO, Yoshihide Fujimoto,  Naohiko Anzai,  Akihiro Hisaka. Exercise training outcomes in patients with chronic heart failure with reduced ejection fraction depend on patient background. Front. Cardiovasc. Med., in press (IF=3.6)
2. Jessica Anindita, Hiroki Tanaka, Takuma Yamakawa, Yuka Sato, Chika Matsumoto, Kota Ishizaki,Taiji Oyama, Satoko Suzuki, Keisuke Ueda, Kenjirou Higashi, Kunikazu Moribe, Kasumi Sasaki, Yumik Ogura, Etsuo Yonemochi, Yu Sakurai, Hiroto Hatakeyama, Hidetaka Akita. Pharmaceutics, 16(2), 181 (2024) (IF=5.4)
3. Yi Liu, Miho Suzuoki, Hiroki Tanaka, Yu Sakurai, Hiroto Hatakeyama, Hidetaka Akita. Lymphatic Endothelial Cells Produce Chemokines in Response to the Lipid Nanoparticles Used in RNA Vaccines. Biol. Pharm Bull., 47(3), 689-707 (2024) (IF=2.0)

Invited Lecture (International)

1. Hiroto Hatakeyama. Exploring factors that exacerbate anaphylaxis to immune checkpoint inhibitors ~ analysis using tumor-bearing mouse models. The 5th Joint Symposium on Pharmaceutical Sciences between Chiba University and Seoul National University. Jan. 31st, 2024. Chiba.
2. Yuta Tamemoto. Clinical science for drug post-marketing of small molecule drugs and antibody therapeutics based on medical bid data analysis. Asian Symposium on Pharmaceutical Sciences for the Next Generation: Clinical Research2. The 144th Annual Meeting of the Pharmaceutical Society of Japan. March 31st, 2024. Yokohama.